Name | 9-cis-β-Carotene |
Synonyms | (9Z)-β-Carotene neo U-β-Carotene 9-cis-β-Carotene Neo-β-carotene U (9Z)-β,β-Carotene (9Z)-beta-Carotene |
CAS | 13312-52-2 |
Molecular Formula | C40H56 |
Molar Mass | 536.87 |
Density | 0.941±0.06 g/cm3(Predicted) |
Boling Point | 654.7±22.0 °C(Predicted) |
BRN | 3227021 |
Storage Condition | -20°C |
In vitro study | 9-cis-β-Carotene (1 μM; 18 hours) formulates with the Miglyol 810 and the“antioxidant mix” is incubated to eye cups. The eye cups are isolated from the neuro-retina attached to the underlying RPE tissue fromRPE65rd12 mouse. It prevents S- and M-cones degeneration and leads to over 2- and 9- fold higher m-opsin and s-opsin positive staining compares to the control group. |
In vivo study | In a mouse model of retinoid cycle defect, RPE65rd12. Mice with an extract of Dunaliella Bardawil algae rich in 9-cis-β-Carotene (9CBC) rescues retinal function and preserves cone structure by oral administration. |
WGK Germany | 3 |
biological activity | 9-cis-β-Carotene, a precursor of the retina, consists of β-carotene oxygenase 1 (BCMO1). Cleavage produced 9-cis-retinal. 9-cis-β-cartene inhibits retinal photoreceptor degeneration and helps restore retinal function in animal models. 9-cis-β-cartene has potential for the Study of congenital stationary night blindness. |